Results

Total Results: 29 records

Showing results for "hospital-associated venous thromboembolism".

  1. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - using estrogen Tamoxifen, 3573; placebo, 3566 50 Total 69 101 0.68 (0.50-0.92) VTE … using estrogen Tamoxifen, 6576; placebo, 6599 55 Total 124 244 0.51 (0.41-0.63) ** VTE … using estrogen Tamoxifen, 1238; placebo, 1233 70 Total 34 36 0.94 (0.59-1.49) ** VTE … using estrogen Tamoxifen, 2700; placebo, 2708 46 Total 19 22 0.87 (0.47-1.60) ** VTE … estrogen receptor; NA = not available; NS = not statistically significant; PE = pulmonary embolism; VTE
  2. www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-screening-1996
    January 01, 1996 - endometrium, and ovary), and with other disorders such as cholelithiasis, obstructive sleep apnea, venousthromboembolism, and osteoarthritis. 8 , 20 , 37 Finally, obesity can affect the quality of life by
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
    September 01, 2005 - estrogen receptor; NA � not available; NS � not statistically significant; PE � pulmonary embolism; VTE … Table 5—Continued Adverse Effects Type Treatment Group, n Placebo Group, n Relative Risk (95% CI) VTE … 11 1.18 (0.53–2.63)† Endometrial cancer 11 5 2.2 (0.86–6.06) All-cause death 25 11 2.27 (1.12–4.60)† VTE … 1.59 (0.93–2.77)† Endometrial cancer 36 15 2.53 (1.35–4.97) All-cause death 57 71 0.81 (0.56–1.16)† VTE … 0.50–8.01)† Stroke 9 5 1.81 (0.61–5.38)† Endometrial cancer NA All-cause death 6 9 0.67 (0.24–1.88)† VTE
  4. www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication
    April 17, 2018 - supplementation and found no significant increase in myocardial infarction, coronary heart disease, stroke, venousthromboembolism, deep vein thrombosis, pulmonary embolism, or hospitalizations for heart failure; ARDs
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/6fMLEz4CfAVoj9YBYVbm73
    April 17, 2018 - supplementation and found no signifi- cant increase in myocardial infarction, coronary heart disease, stroke, venousthromboembolism, deep vein thrombosis, pulmonary em- bolism, or hospitalizations for heart failure;
  6. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.
  7. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-depression-suicide-risk-adults
    June 20, 2023 - Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zk8YxjaQxLGUTtt__nBQB_
    September 09, 2021 - Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
    May 06, 2022 - Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: